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tExcessive body weight is associated with
additional loss of quality of life in
children with asthma
Rene´ van Gent, MD,a Cornelis K. van der Ent, MD, PhD,b Maroeska M. Rovers, PhD,c
Jan L. L. Kimpen, MD, PhD,d Liesbeth E. M. van Essen-Zandvliet, MD, PhD,e and
Gea de Meer, MD, PhDf,g Veldhoven, Utrecht, Hilversum, and Groningen, The NetherlandsA
st
h
mBackground: Asthma and excessive body weight frequently
coexist, whereas the exact relationship between the 2
diseases is unknown.
Objective: To study whether asthma combined with excessive
bodyweight has a greater effect on quality of life in children than
the separate effects of asthma or excessive body weight alone.
Methods: In a cross-sectional design, 1758 school children (age
7-10 years) participated: 4 study groups were composed of
children with asthma and with/without excessive body weight,
and healthy controls with/without excessive body weight.
Diagnosis of asthmawas defined by either a doctor’s diagnosis or
by core questions of the International Study of Asthma and
Allergies in Childhood questionnaire in combination with either
reversible airway obstruction or bronchial hyperresponsiveness.
Excessive body weight was defined by using international cutoff
points for body mass index. Quality of life was evaluated by the
Pediatric Asthma Quality of Life Questionnaire.
Results: For all domains of quality of life, children with both
asthma and excessive body weight had lower scores than
children with either asthma alone or excessive body weight
alone. Compared with healthy controls, the score was 25%
lower in children with asthma and excessive body weight,
14% lower in children with asthma and normal weight, and
only 1% lower in overweight controls.
Conclusion: Excessive body weight is associated with an
additional decrease in quality of life in children with asthma.
Clinical implications: Clinicians should be aware of the
interaction between asthma and excessive body weight and the
effect on quality of life and should give extra attention to
children with both conditions. (J Allergy Clin Immunol
2007;119:591-6.)
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doi:10.1016/j.jaci.2006.11.007Asthma and excessive body weight frequently coexist,
but the underlying mechanism remains obscure. Recently,
Hallstrand et al1 reported shared genetic risks for asthma
and obesity. Other potential mechanisms include obe-
sity-related changes in lung volumes and adipocyte-
derived factors that might alter airway smooth muscle
function.2 Moreover, it was recently hypothesized that
the elementary lesion of obesity might be inflammatory
in origin, making a link with asthma as an inflammatory
condition more plausible.3 Furthermore, the decreased
activity level associated with poorly controlled asthma
may predispose a child to gain excessive body weight.
Although a considerable number of studies using different
designs indicate that excessive body weight might in-
crease the risk of asthma development, the topic remains
controversial because of potential methodologic limita-
tions including definitions of asthma, different anthropo-
metric measures, directionality of causality, and residual
confounding in many of these studies.4
In addition to clinical measures of airway status (such as
airway caliber and markers of inflammation), quality of
life provides valuable information about functional im-
pairment (physical, emotional, and social) that is relevant
to a patient’s everyday life.5 Children with excessive body
weight are less fit andmay havemore symptoms of breath-
lessness on exertion than their healthy peers.
Because asthma and excessive body weight frequently
coexist, we hypothesized that excessive bodyweightmay be
related to an additional decrease in quality of life in children
with asthma. Therefore, in children with asthma, we studied
the combined effect of asthma and excessive body weight
on quality of life compared with the effect of asthma with
normal weight alone, and also compared with healthy
controls with normal weight or excessive body weight.
METHODS
Population and study protocol
From 2002 to 2005, we conducted a survey among primary school
children age 7 to 10 years in the southern region of The Netherlands.
Abbreviations used
BHR: Bronchial hyperresponsiveness
BMI: Body mass index
FVC: Forced vital capacity
PAQLQ: Pediatric Asthma Quality of Life Questionnaire591
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tThe study protocol was composed of a questionnaire for parents on
respiratory symptoms, demographic and household characteristics,
and the child’s assessment of height and weight, lung function, and
assessment of airway reversibility to salbutamol. First, the ISAAC
questionnaire and a consent form were distributed at participating
schools to all eligible children. Lung function and assessment of
airway reversibility were performed at school by experienced lung
function technicians in all children who gave written consent. All
eligible children with asthma symptoms (wheeze or dry cough in the
past 12 months) or with proven airway reversibility to salbutamol
were invited to the Ma´xima Medical Center in Veldhoven for
bronchial challenge with hypertonic saline.
For the current study, asthma was considered if 1 of the following
criteria was fulfilled: (1) a parent’s report of asthma diagnosis, with
or without airway reversibility or bronchial hyperresponsiveness
(BHR); or (2) asthma symptoms in the past 12 months combined
with airway reversibility or BHR. For each child with asthma, a
healthy control was selected randomly from the same classroom.
Healthy controls had no asthma diagnosis, no asthma symptoms in
the last 12months, and no airway reversibility to salbutamol. Selected
healthy controls were invited for bronchial challenge as well. Quality
of life was assessed in children with asthma and healthy controls
after completing the bronchial challenge with hypertonic saline.
Questionnaires were returned by mail. Parents received a letter with
the results of the symptom questionnaire and lung function tests
2 weeks after finishing the study protocol.
Approval was obtained from both the National Committee on
Research InvolvingHumanSubjects (TheHague, TheNetherlands) and
the local Hospital Ethics Committee. Informed written consent was
obtained from the parents of all participating children at the start of the
study, when they returned the questionnaire. Apart from a small present
for the children, there was no compensation for the participants.
Body mass index
Before lung function testing, height and weight were assessed by
trained research assistants. The child was stretched against the wall,
and height was measured to the nearest 0.1 cm, without wearing
shoes. Children were weighed on a calibrated electronic step-scale,
wearing no shoes and only light indoor clothing with empty pockets.
Body mass index (BMI) was calculated from height and weight
measurements (BMI 5 weight [kg]/[height (m)]2). Excessive body
weight was defined using international cutoff points for children
with overweight and obesity stratified by sex, which are defined to
match with the adult cutoff point of a BMI of 25 kg/m2 (overweight)
and 30 (obesity) kg/m2 at 18 years of age.6
Questionnaire
Parents completed a questionnaire that included the ISAAC core
questions on symptoms of asthma, rhinitis, and eczema.7 Additional
data were collected on household characteristics such as parental
education, passive smoking, and pet ownership. Questions asked a
response of yes/no. Asthma symptoms were defined as wheeze or a
dry cough at night in the past 12 months.
Lung function testing
Maximal flow-volume curves were measured by using a hand-
held spirometer (Vitalograph Ltd, Buckingham, United Kingdom)
according to the European Respiratory Society guidelines.8 Airway
reversibility was defined as an increase of FEV1 of10% of the pre-
dicted value 10minutes after administration of 800mg salbutamol us-
ing a volumatic spacer (GSK, Uxbridge, United Kingdom).9
Hypertonic saline testing
Bronchial hyperresponsiveness was assessed by inhalation chal-
lenge with nebulized hypertonic (4.5%) saline by using an ultrasoundnebulizer (Klava 2000/4000; Klava Eltromed, Bielefeld, Germany)
according to the ISAAC protocol.10 All children were asked to with-
hold all asthma medications for at least 12 hours beforehand.
Children with a baseline FEV1  75% were excluded. The children
inhaled the saline for periods of increasing duration: 0.5, 1, 2, 4,
and 8 minutes. FEV1 was measured 1 minute after each inhalation
period, and the next inhalation period started after 3 minutes.
Bronchial challenge was stopped if FEV1 had fallen at least 15%
from baseline or if the total inhalation period of 15.5 minutes had
been completed. A child was defined as having BHR if FEV1 had
dropped by 15% from baseline during the inhalation challenge.
Quality of life
Quality of life was measured with the Pediatric Asthma Quality of
Life Questionnaire (PAQLQ) for children.11 Children were asked to
recall impairments they experienced the last week; for instance,
‘‘How much did wheezing bother you during the past week?’’
Scores range from 1 to 7, with 7 indicative of maximal quality of
life. The PAQLQ consists of 3 domains: the emotions domain,
activity domain, and symptom domain. Individual items within the
PAQLQ were equally weighted. Results are expressed as the mean
score per domain as well as for overall quality of life. Raat et al12
showed good validation of the PAQLQ in a Dutch population.
Statistical analysis
All data of the questionnaires were double-entered into the database
by using Microsoft Access software. Data were analyzed using the
statistical package SPSS version 13.0 (SPSS Inc, Chicago, Ill). To an-
alyze potential differences in clinical characteristics (ie, asthma symp-
toms, lung function, and quality of life), x2 tests and ANOVA (with a
Bonferroni post hoc test)wereused.Toadjust for potential confounders
(eg, parental asthma, current parental smoking, and the education level
of parents), multivariate regression analyses were performed. In this
model, we tested the effect of all potential confounders 1 by 1. The
following model was tested: quality of life 5 a 1 b 1 3 group 1 b
2 3 potential confounder. Because the estimates were not influenced
by these possible confounders, crude effect estimates were presented.
To evaluate the interaction between excessive overweight and asthma,
wecompared the combined effect of asthma and excessive bodyweight
with the sum of separate effects as described by Pearce.13
RESULTS
Participants
Of 44 eligible schools, 41 participated in the study.
Reasons for nonparticipation were recent involvement in
another study (n 5 2) and school policy (n 5 1).
Subsequently, all 2745 children and their parents were
invited for the study, of whom 1758 (64%) agreed. We
excluded 144 children from further analysis because of
missing questionnaire data (n 5 60) or refusal to partic-
ipate in bronchial challenge testing (n5 31). Additionally,
53 children did not complete the bronchial challenge test
because of nausea or coughing (n 5 3) or were unable to
meet technical conditions (n 5 50). All children with a
parent’s report of asthma reported asthma symptoms
(wheeze or dry cough at night) in the last 12 months.
For each child with asthma, a healthy control was selected
from the same classroom. There were no differences in
FEV1 and forced vital capacity (FVC) between the se-
lected control group and the whole nonasthmatic popula-
tion: 98% predicted for FEV1 and 93% for FVC. The final
J ALLERGY CLIN IMMUNOL
VOLUME 119, NUMBER 3






















tTABLE I. Characteristics of the 4 study groups*
Asthma Healthy controls
Normal weight Excessive body weight Normal weight Excessive body weight
n (%) 171 (84) 33 (16) 174 (87) 26 (13)
Sex, n (%)
Male 97 (57) 17 (52) 86 (49) 12 (46)
Female 74 (43) 16 (48) 88 (51) 14 (54)
Mean age 6 SD (y) 9.3 (0.8) 9.5 (0.8) 9.4 (0.7) 9.6 (0.6)
Mother asthma ever, n (%) 28 (19) 6 (19) 4 (3) 0 (0)
Father asthma ever, n (%) 16 (12) 2 (8) 7 (5) 5 (24)
Mother current smoker, n (%) 24 (16) 10 (32) 36 (22) 5 (22)
Father current smoker, n (%) 34 (23) 12 (40) 40 (24) 2 (8)
Mother’s education level
Low, n (%) 24 (16) 5 (16) 24 (15) 9 (37)
Moderate, n (%) 73 (49) 15 (48) 88 (53) 6 (26)
High, n (%) 53 (35) 11 (36) 53 (32) 9 (37)
Father’s education level
Low, n (%) 24 (17) 10 (38) 29 (18) 7 (32)
Moderate, n (%) 52 (38) 9 (35) 59 (37) 6 (27)
High, n (%) 62 (45) 7 (27) 73 (45) 9 (41)
*n, Absolute number for the weight or disease group. %, Percent of total weight or disease group; however, because of missing values, data can be lower
or higher than calculated.study population was composed of 1614 children, of
whom 204 (13%) had asthma (171 [84%] with normal
weight and 33 [16%] with excessive body weight), and
200 were defined as healthy controls (174 [87%] with nor-
mal weight and 26 [13%] with excessive body weight).
The number of children with overweight was 24 (73%)
in the asthma group and 23 (89%) in the healthy controls.
The number of obese children was 9 (27%) in the asthma
group and 3 (12%) in the healthy controls.
Table I presents the characteristics of children with
asthma and healthy controls. The occurrence of excessive
body weight was similar for both groups. Children with
asthma with excessive body weight more frequently had
a smoking father (P < .05) and more frequently used in-
haled corticosteroids (P < .05).
Table II presents clinical characteristics of childrenwith
asthma and healthy controls.Wheeze or dry cough at night
was equally distributed in children with asthma with nor-
mal weight or overweight. There were also no differences
in symptoms on the basis of the ISAAC questionnaire.
Lung function reversibility was most frequent in normal
weight children with asthma (43% of children). Bronchial
hyperresponsiveness was most frequent in children with
asthma combined with excessive body weight (73% of
children). In healthy controls with excessive body weight,
bronchial hyperresponsiveness was also more frequent
than in healthy controls with normal weight (respectively,
19% and 9%; P < .001). Lung function reversibility was
present in 24% of children with a parent’s report of
asthma. Bronchial hyperresponsiveness was present in
47% of these children.
Quality of life
Fig 1, A to D, and Table III present data on the separate
and combined effects of asthma and excessive body weight
for different domains of quality of life. Children withasthma combined with excessive body weight had the low-
est quality of life comparedwith all other groups of children
for all domains (P < .01). For the combined domain, scores
were 5.2 (95% CI, 4.5-5.9) in children with asthma and ex-
cessive body weight, 6.0 (95%CI, 5.8-6.2) in children with
asthmawith normalweight, 6.9 (95%CI, 6.9-7.0) in healthy
controls with excessive body weight, and 7.0 (95% CI,
6.6-7.0) in healthy controls with normal weight (Fig 1, D;
P < .05 for all comparisons, except between healthy con-
trols with excessive body weight and with normal weight).
Table III presents percentage differences in the quality-
of-life scores among 3 of the study groups compared with
healthy controls with normal weight. Compared with
healthy controls with normal weight, quality-of-life scores
for the combined domain were respectively 14% lower in
children with asthma and normal weight and 1% lower in
healthy controls with excessive body weight. On the basis
of the separate effects for asthma and overweight, we ex-
pected a 15% lower score; however, the score for the com-
bined effect in overweight children with asthma proved
to be 25% lower.
DISCUSSION
In the current study, quality of life in children with both
excessive body weight and asthma was lower than expected
on the basis of the sumof the separate effects of asthma alone
or excessive body weight alone. Children with asthma and
excessive body weight had a lower quality of life compared
with childrenwith asthma and normalweight, and compared
with healthy controls irrespective of their weight.
Our results are in agreement with results in adults that
showed a significant association between BMI and quality
of life in adults with asthma.14,15 Data on the effect of
asthma in children with excessive body weight in the
J ALLERGY CLIN IMMUNOL
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body weight P value
n (%) 171 (84) 33 (16) 174 (87) 26 (13)
BMI (mean) 16.0 21.9 15.8 20.9
Wheeze, n (%) 115 (67) 21 (64) 0 0
Dry cough at night, n (%) 53 (31) 11 (33) 0 0
Lung function parameters
Mean baseline FEV1 % predicted 95 98 100 101 .001
Mean baseline FVC % predicted 91 95 94 94 NS
Change in FEV1 after bronchodilation (%) 8.6 2.1 1.7 0.6 <.05§
Reversibility 10%, n (%) 73 (43) 12 (36) 0 0 <.001§k{
BHR, n (%) 102 (60) 24 (73) 16 (9) 5 (19) <.001§k{
FEV1 <75%, n 1 0 0 0
Medication
Inhaled corticosteroids, n (%) 52 (30) 14 (46) 0 (0) 0 (0)
Bronchodilator, n (%) 73 (43) 15 (45) 0 (0) 0 (0)
Cromoglycate, n (%) 2 (1) 0 (0) 0 (0) 0 (0)
Theophylline 0 (0) 0 (0) 0 (0) 0 (0)
Oral steroids 0 (0) 0 (0) 0 (0) 0 (0)
NS, Not significant.
*n, Absolute number for the weight or disease group. %, Percent of total weight or disease group; however, because of missing values, data can be lower
or higher than calculated.
Significant difference between patients with asthma with normal weight and healthy controls with normal weight.
Significant difference between patients with asthma with normal weight and with excessive body weight.
§Significant difference between patients with asthma with normal weight and healthy controls with excessive body weight.
kSignificant difference between patients with asthma with excessive body weight and healthy controls with excessive body weight.
{Significant difference between patients with asthma with excessive body weight and healthy controls with normal weight.population are scarce. Blandon et al16 found a lower qual-
ity of life in children with asthma recruited from a popula-
tion attending a specialized allergy and immunology
clinic. In a sample of inner-city children, Belamarich et al17
reported that obese children with asthma had more un-
scheduled emergency department visits and receivedmore
medication than nonobese children. The effect of over-
weight and obesity is higher with increasing BMI. For in-
stance, among 3457 subjects in the Framingham Study,
those who were overweight at age 40 years lived about 3
years less and those who were obese at age 40 years lived
6 to 7 years less than those who were not.18 In the same
cohort, the relative risk in obese for vascular disease was
higher for obese than for overweight adults.19
In our study, children with asthma combined with
excessive body weight were more often treated with
inhaled corticosteroids than children with asthma with-
out excessive body weight. Possible explanations for
this phenomenon are a different perception of dyspnea
by children, greater awareness of respiratory complaints
by parents, or a different coping behavior with respira-
tory complaints in these children with excessive body
weight.
To our knowledge, this is the first community-based
study in children to evaluate the relationship among
excessive body weight, asthma, and quality of life mea-
sured with a disease-specific, validated, and well known
quality-of-life questionnaire. Disease-specific question-
naires have a higher discriminative property and sensitivityto detect small differences for the disease of interest.20-22
In contrast, general questionnaires on quality of life tend
to be designed to assessmoderate or severe effect of chronic
conditions on children’s quality of life, which make them
less sensitive to small differences between groups.
The clinical interpretation of differences in quality of
life is difficult because experience in their use is still
limited. Juniper et al20 proposed a difference of 0.5 or
higher as being clinically relevant for the PAQLQ.
Knorr et al23 studied the effect of treatment in children
with asthma 6 to 14 years old and observed a significant
improvement in both FEV1 and quality-of-life scores
(with 0.4 for the emotional domain and 0.5 for the activity
domain). In light of these studies, our results suggest a
clinically relevant impairment of quality of life in children
with asthma with excessive body weight.
Our results suggest that treatment in children should be
aimed at both asthma and excessive body weight. We
know from adults that the response to different asthma
medications is influenced by an increasing BMI.24 The
effect of placebo or corticosteroid treatment on asthma
symptom-free days was lower in obese patients with
asthma, whereas this effect was not seen in treatment
with leukotriene antagonists. Data on children with
asthma combined with excessive body weight are still
scarce. However, the combination of health problems
makes it likely that a combined treatment for both con-
ditions by a multidisciplinary team (including a psycholo-
gist and a dietitian) is beneficial for the quality of life in
J ALLERGY CLIN IMMUNOL
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tFIG 1. A, Separate and joint effects of asthma and excessive body weight for the emotions domain. P < .05 for
all comparisons except between healthy controls with normal weight and healthy controls with excessive
body weight. B, Separate and joint effects of asthma and excessive body weight for the symptom domain.
P < .05 for all comparisons except between healthy controls with normal weight and healthy controls with
excessive body weight. C, Separate and joint effects of asthma and excessive body weight for the activity
domain. P < .05 for all comparisons except between healthy controls with normal weight and healthy con-
trols with excessive body weight. D, Separate and joint effects of asthma and excessive body weight for
the combined domain. P < .05 for all comparisons except between healthy controls with normal weight






















Symptom domain 1.5 (0.8-2.1) 21% 0.9 (0.7-1.1) 13% 0.2 (0.0-0.4) 3% <.01*
Emotions domain 0.7 (0.3-1.3) 10% 0.3 (0.2-0.6) 4% 0 (0-0.1) 0% <.05*
Activity domain 2.0 (1.1-2.8) 29% 1.4 (0.8-1.7) 20% 0.1 (0.0-0.7) 1% <.05*
Combined domain 1.8 (1.0-2.5) 25% 1.0 (0.8-1.2) 14% 0.1 (0.0-0.4) 1% .001*
*Significant difference in quality of life scores among all study groups except between healthy controls with excessive body weight and healthy controls with
normal weight.these children. Caloric restriction and increasing energy
expenditure are hallmarks in the treatment of excessive
body weight. Ford et al25 suggested a need for weight
control programs among adults with asthma, because theyfound that many adults with asthma did not use recom-
mended approaches of caloric restriction and adequate
physical activity. Further studies are needed to establish
which strategy is best in children.
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tUntil now, no reports have been available about the
influence of a reduction in excessive body weight on
asthma severity in children, and there are few evidence-
based guidelines for intervention regarding excessive body
weight in children.26 In adults, a reduction in excessive
body weight by medical treatment and surgical procedures
has resulted in a reduction of asthma symptoms, medica-
tion usage, and severity, and in improvement of lung func-
tion, indicating a possible causal relationship.27-29
When considering our results, some possible limita-
tions of this study should be discussed. First, the ISAAC
questionnaire used in this study depended on the recall of
asthma symptoms by parents. Recall by parents can be
faulty. Further, parents may not witness every asthma
symptom a child experiences. Nonetheless, patient report
of asthma symptoms has long been a key factor in
physician’s decision making, and the ISAAC question-
naire mimics the questions they pose as part of assessment.
Second, misclassification of asthma is possible. However,
we believe that using a combination of the well known and
validated ISAAC questionnaire and objective measures
such as lung function reversibility and BHR resulted in
the best possible clinical definition of asthma. Third, be-
cause of the cross-sectional design of this study, we can
not speculate on the causal relationship between asthma
and excessive body weight and the effect on quality-of-
life. Fourth, one might argue that asthma-specific
quality-of-life questionnaires are inappropriate to be
used in healthy controls. However, the PAQLQ also in-
cludes questions on the effect of respiratory symptoms
without making reference to asthma. Therefore, we have
considered them appropriate for use in children serving
as healthy controls. Our observations of the highest scores
in healthy controls that approximated the maximum value
may be considered a confirmation.
In conclusion, excessive body weight is associated
with an additional decrease in quality of life in children
with asthma. Clinicians should realize that children with
asthma need extra attention if they also have excessive
body weight. We therefore consider that treatment by
specialized multidisciplinary teams will have the largest
beneficial effect in these children.
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